Effect of Intravenous 25OHD Supplementation on Bone Turnover and Inflammation in Prolonged Critically Ill Patients
暂无分享,去创建一个
G. Van den Berghe | H. Møller | C. Mathieu | R. Bouillon | I. Vanhorebeek | T. Hansen | Catherine Ingels | I. Derese | P. Wouters | J. Billen | S. V. Van Cromphaut | Alexander Dehouwer
[1] R. Bouillon,et al. Is calcifediol better than cholecalciferol for vitamin D supplementation? , 2018, Osteoporosis International.
[2] G. Van den Berghe,et al. Endocrine and Metabolic Alterations in Sepsis and Implications for Treatment. , 2018, Critical care clinics.
[3] Joseph M Betz,et al. General Steps to Standardize the Laboratory Measurement of Serum Total 25-Hydroxyvitamin D. , 2017, Journal of AOAC International.
[4] J. Greeves,et al. Reference intervals for serum 24,25-dihydroxyvitamin D and the ratio with 25-hydroxyvitamin D established using a newly developed LC-MS/MS method. , 2017, The Journal of nutritional biochemistry.
[5] R. Bouillon. Comparative analysis of nutritional guidelines for vitamin D , 2017, Nature Reviews Endocrinology.
[6] H. Weng,et al. Randomised trials of vitamin D3 for critically ill patients in adults: systematic review and meta-analysis with trial sequential analysis , 2017, Intensive Care Medicine.
[7] A. Ginde,et al. Clarification needed for the systematic review of vitamin D trials in the ICU , 2017, Intensive Care Medicine.
[8] G. Berghe. On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. , 2016 .
[9] J. Eisman,et al. Bone Failure in Critical Illness , 2016, Critical care medicine.
[10] M. Melamed,et al. FGF-23 and cardiovascular disease: review of literature , 2016, Current opinion in endocrinology, diabetes, and obesity.
[11] K. Christopher. Vitamin D and critical illness outcomes , 2016, Current opinion in critical care.
[12] G. Martin,et al. High dose vitamin D administration in ventilated intensive care unit patients: A pilot double blind randomized controlled trial , 2016, Journal of clinical & translational endocrinology.
[13] P. Dhawan,et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. , 2016, Physiological reviews.
[14] J. Kaufman,et al. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study. , 2015, Bone.
[15] K. Amrein,et al. Understanding vitamin D deficiency in intensive care patients , 2015, Intensive Care Medicine.
[16] K. Christopher. Vitamin D supplementation in the ICU patient , 2015, Current opinion in clinical nutrition and metabolic care.
[17] D. Nebel,et al. Vitamin D3 modulates the innate immune response through regulation of the hCAP-18/LL-37 gene expression and cytokine production , 2015, Inflammation Research.
[18] H. D. de Geus,et al. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis , 2014, Critical Care.
[19] A. Berghold,et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. , 2014, JAMA.
[20] E. Díaz,et al. Risks for multidrug-resistant pathogens in the ICU , 2014, Current opinion in critical care.
[21] Chul-woo Yang,et al. Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis , 2014, Journal of immunology research.
[22] W. März,et al. Association of bone turnover markers with mortality in men referred to coronary angiography , 2013, Osteoporosis International.
[23] C. Mathieu,et al. Uremia Suppresses Immune Signal-Induced CYP27B1 Expression in Human Monocytes , 2012, American Journal of Nephrology.
[24] C. Camargo,et al. Vitamin D in acute stress and critical illness , 2012, Current opinion in clinical nutrition and metabolic care.
[25] C. Cox. Persistent Systemic Inflammation in Chronic Critical Illness , 2012, Respiratory Care.
[26] L. Moldawer,et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care , 2012, The journal of trauma and acute care surgery.
[27] D. Bikle. Vitamin D and Bone , 2012, Current Osteoporosis Reports.
[28] K. Amrein,et al. Vitamin D and the critically ill patient , 2012, Current opinion in clinical nutrition and metabolic care.
[29] R. Bouillon. Why modest but widespread improvement of the vitamin D status is the best strategy? , 2011, Best practice & research. Clinical endocrinology & metabolism.
[30] C. Gordon,et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.
[31] J. M. Mata-Granados,et al. Evaluation of vitamin D endocrine system (VDES) status and response to treatment of patients in intensive care units (ICUs) using an on-line SPE-LC-MS/MS method , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[32] J. Eisman,et al. Vitamin D deficiency in critically ill patients. , 2009, The New England journal of medicine.
[33] J. Eisman,et al. Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality? , 2009, Intensive Care Medicine.
[34] M. Harboe,et al. Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis , 2009, Scandinavian journal of immunology.
[35] J. Marshall,et al. The immune system in critical illness. , 2008, Clinics in chest medicine.
[36] G. Van den Berghe,et al. Effect of insulin therapy on coagulation and fibrinolysis in medical intensive care patients* , 2008, Critical care medicine.
[37] S. Atkinson. Vitamin D status and bone biomarkers in childhood cancer , 2008, Pediatric blood & cancer.
[38] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[39] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[40] G. Van den Berghe,et al. Bone turnover in prolonged critical illness: effect of vitamin D , 2003, The Journal of clinical endocrinology and metabolism.
[41] S. Moestrup,et al. Characterization of an enzyme-linked immunosorbent assay for soluble CD163 , 2002, Scandinavian journal of clinical and laboratory investigation.
[42] H. DeLuca,et al. Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] C. Mathieu,et al. In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[45] G. Choukroun,et al. 7-84 PTH or aluminum antagonism in the resistance of uremic bone to the remodeling effect of endogenous PTH? , 2001, Kidney international.
[46] J. Mechanick,et al. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. , 2000, Chest.
[47] H. DeLuca,et al. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.
[48] J. Mechanick,et al. Bone hyperresorption is prevalent in chronically critically ill patients. , 1998, Chest.
[49] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[50] D. Vanderschueren,et al. Homologous radioimmunoassay of human osteocalcin. , 1992, Clinical chemistry.
[51] A. Mantovani,et al. Impairment of cytokine production in mice fed a vitamin D3-deficient diet. , 2013, Immunology.
[52] R. Bouillon,et al. Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. , 1990, Clinical chemistry.
[53] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[54] P. D. de Moor,et al. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. , 1981, The Journal of clinical investigation.